Abstract
The arm of this review was to help general pediatricians and primary care physicians in diagnosing and managing cow’s milk protein allergy in exclusively breast-fed infants.
Allergic proctocolitis is a cause of rectal bleeding in exclusively breast-fed infants aged from 1 to 6 months.It is due to cow’s milk protein transferred via breast milk. Diagnosis is based on clinical features and recovery after dietetic therapy. Rectal bleeding generally resolves within 72-96 hours of cow’s milk protein maternal avoidance. Most infants tolerate cow’s milk by their first birthday.
Keywords: Allergic proctocolitis, α-S1-casein, β-lactoglobulin, blood streaked stool, breast-fed infants, cow’s milk proteins, non-IgE mediated immunologic reactions.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Refractory Proctocolitis in the Exclusively Breast-Fed Infants
Volume: 14 Issue: 1
Author(s): Marina Atanaskovic-Markovic
Affiliation:
Keywords: Allergic proctocolitis, α-S1-casein, β-lactoglobulin, blood streaked stool, breast-fed infants, cow’s milk proteins, non-IgE mediated immunologic reactions.
Abstract: The arm of this review was to help general pediatricians and primary care physicians in diagnosing and managing cow’s milk protein allergy in exclusively breast-fed infants.
Allergic proctocolitis is a cause of rectal bleeding in exclusively breast-fed infants aged from 1 to 6 months.It is due to cow’s milk protein transferred via breast milk. Diagnosis is based on clinical features and recovery after dietetic therapy. Rectal bleeding generally resolves within 72-96 hours of cow’s milk protein maternal avoidance. Most infants tolerate cow’s milk by their first birthday.
Export Options
About this article
Cite this article as:
Atanaskovic-Markovic Marina, Refractory Proctocolitis in the Exclusively Breast-Fed Infants, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (1) . https://dx.doi.org/10.2174/1871530314666140121145800
DOI https://dx.doi.org/10.2174/1871530314666140121145800 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Overview of Genomic Insights into Chicken Growth Traits Based on Genome- Wide Association Study and microRNA Regulation
Current Genomics Correlation Between ROS Production and InsP3 Released by Granulocytes from Type 1 Diabetic Patients in a cAMP-Dependent Manner
Current Aging Science Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Editorial: Bioactive Substances from Medicinal Plants for Metabolic Disorders
Current Medicinal Chemistry Gene Delivery Strategies Targeting Stable Atheromatous Plaque
Current Pharmaceutical Design Biodegradable Polymeric Nanoparticles as the Delivery Carrier for Drug
Current Drug Delivery Genetic Variation and Atherosclerosis
Current Genomics Oxidative Stress, Antioxidants, and Endothelial Function
Current Medicinal Chemistry Long Term Complications in Pediatric Liver Transplant Recipients: What Every Pediatrician Should Know
Current Pediatric Reviews Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Current Diabetes Reviews Aging and Proteins: What Does Proteostasis Have to Do with Age?
Current Molecular Medicine Patent Selections
Recent Patents on Anti-Infective Drug Discovery Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Remote Neural Stimulation Using Magnetic Nanoparticles
Current Medicinal Chemistry Homocysteine, Cardiovascular Inflammation, and Myocardial Remodeling
Cardiovascular & Hematological Disorders-Drug Targets Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Current Bioactive Compounds Intracellular Calcium, Endothelial Cells and Angiogenesis
Recent Patents on Anti-Cancer Drug Discovery Transcription Factors and Regulators Pathway-focused Genes Expression Analysis in Patients with Different Forms of Thyroid Pathology
Current Pharmaceutical Biotechnology Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine Fighting Diabetes: Lessons from Xenotransplantation and Nanomedicine
Current Pharmaceutical Design